Autoimmune

28
Hipersensitif tipe I

Transcript of Autoimmune

Page 1: Autoimmune

Hipersensitif tipe I

Page 2: Autoimmune

POLLEN

Page 3: Autoimmune

NORMAL

Page 4: Autoimmune
Page 5: Autoimmune

HIPERSENSITIF TIPE II

Page 6: Autoimmune
Page 7: Autoimmune

HIPERSENSITIFITAS TIPE IV

Page 8: Autoimmune

Immune deficiency state

Infection : CD4> 500 x 106

Latent period : CD4200 - 500 x 106

AIDS : CD4 < 200 x 106

Common AIDS-associated disease and site*Brain: tumours (limphomas), inflammation

(encephalitis), dimentia*Mouth: trachea,oesophagus (candidiasis)*Lung:pneumocytis carinii infection, fungal

infection, TBC*Intestine: protozoal, salmonella infection*Skin: Kaposi’s sarcoma, fungal infection,herpes

zoster

Page 9: Autoimmune

AIDS MECHANISM

Page 10: Autoimmune
Page 11: Autoimmune

AUTOIMMUNE

Autoimmune diseases result from, or are associated with an immune response againts the individual’s own cell, or in some cases cell product. Although both humoral dan cell mediated immunity are involved, it is thought that change in the latter of primary importantce

Etiology:The etiology of autoimmune diseases is not established,

but clues to their genesis are available

Page 13: Autoimmune

Figure 1. Requirements for the development of an autoimmune disease.The immune response of a genetically predisposed individual to an environmental pathogen, in association with defects in immunoregulatory mechanisms, can lead to the development of an autoimmune disease. The importance of the single components represented in this Venn diagram may vary between individuals and diseases. However, the appearance of an autoimmune disease requires the convergence of all three components. T, T cell; B, B cell; DC, dendritic cell.

Bob Crimi

Page 14: Autoimmune

The reason for the breakdown of tolerance involve

1. Antigenic abnormalitya. Cell surface antigen modified

by drug or chemicalsb. Cell antigen modified by

proteolysis associated with disease processes, particularly inflammation, when “new”antigen are formed

c. Microbial cross-reacting antigen

2. Immune dysregulation

Abnormal pesence/

activity of auto-reaktive T cells

+/- failure of regulatory cells

Page 15: Autoimmune

CD4 cell activity increase

Cytotoxic T Cells promed

B cell activity

Auto-antibodies

Cytokines (delayed hyper-sensitivity re-

action)

Ag/Ab+complement

CELL DESTRUCTION

Page 16: Autoimmune

ORGAN SPESIFIK

Antibody or cell mediated reaction to

Target organ

Associated disease

Thyroid cells and hormone or TSH receptor

Thytroid

Primary myxoedema,Hashimoto’s disease (autoimmune thyroiditis), Thyrotoxikosis (Graves’ disease)

Parietal cells intrinsic factor/intrinsic factor B12 complex

Stomach

Pernicious anemia

Page 17: Autoimmune

SAMBUNGAN

Red blood cells Red blood cells Haemolytic anemia

Pancreatic islet beta cells

Pancreas Type I diabetes

Adrenal cortical cell, ACTH receptor

Adrenal Addison’s disease

Parathyroid cells Parathyroid Prymary hypoparathyroidism

Acetylcholline receptor

Voluntary muscle Myasthemia gravis

Page 18: Autoimmune

NON-ORGAN SPECIFIC

Antibody to Target organ Associated Disease

Mitochondria Liver Primary biliary cirrosis

Smooth muscle

Nuclear constituents

IgG

Many other body protein

Liver Autoimmune chronic hepatis

Skin and muscle

The connective tissue disease, Dermatomyositis, Rhematoid arthritis, Systemic lupus erythematosus (SLE), Progressive systemic sclerosis

Skin, kidney,endocardium, blood vessels, joints

Page 19: Autoimmune
Page 20: Autoimmune
Page 21: Autoimmune
Page 22: Autoimmune

HASHIMOTO DISEASE

Page 23: Autoimmune

APPLIED IMMUNOLOGY

I.Immunohistochemical Identification

Page 24: Autoimmune
Page 25: Autoimmune

Immunohistochemical

Page 26: Autoimmune

Immunohistochemical

Page 27: Autoimmune

Immunoflorescent

Page 28: Autoimmune

TISSUE TRANSPLANTATION

Antigen presentingCell in graft

Present “foreign”HLA antigen

Cell mediatedimmunity

Cytokines

Rejevtion

Host T cell

Spesific T cell immuneRespons to HLA antigen

Cytotoxic T cells

Attack graff cell(particularly vascular

endothelium